Distribution: Public Hospitals Subject:

First Page		Document Content
Date: 2015-03-18 23:30:43 Pharmaceutical sciences Medicine Pharmaceutical industry Ribavirin Triazoles Interferon Peginterferon alfa-2a Capsule Diluent Pharmacology Antivirals Dosage forms		Distribution: Public Hospitals Subject: Add to Reading List Source URL: www.health.vic.gov.au Download Document from Source Website File Size: 22,22 KB Share Document on Facebook

	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	IMPORTANT PLEASE READ PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part "Product Monograph" DocID: 1uNBi - View Document
	Evaluation of Interferon-gamma-Producing T Cells DocID: 1uFKZ - View Document
	PRODUCT MONOGRAPH INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vial DocID: 1umTG - View Document
	  Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.: µg) DocID: 1u1rK - View Document